Text Size

Evaluation of the H1-coil Deep TMS in the Treatment of Negative Symptoms and Cognitive Deficit in Schizophrenia

This study has been completed.
Sponsor:
Information provided by:
Shalvata Mental Health Center
ClinicalTrials.gov Identifier:
NCT00445926
First received: March 8, 2007
Last updated: May 5, 2010
Last verified: May 2010
History of Changes
  Purpose

The study evaluates the feasibility of using a 4 week stimulation protocol with the deep TMS H-coils for the treatment of negative symptoms and cognitive deficit in schizophrenia patients


Condition Intervention Phase
Schizophrenia
 Device: deep TMS H-coil
 Phase 1

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Deep TMS With the H Coils as a Novel Strategy for the Treatment of Negative Symptoms of Schizophrenia

Resource links provided by NLM:

MedlinePlus related topics: Schizophrenia
U.S. FDA Resources

Further study details as provided by Shalvata Mental Health Center:

Study Start Date: July 2006
Study Completion Date: May 2009
Primary Completion Date: May 2009 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • DSM IV Diagnosis of Schizophrenia
  • PANNS Negative > 21

Exclusion Criteria:

  • risk factors for convulsions
  • PANNS positive > 24
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00445926

Locations
Israel
Shalvata MHC
Hod Hasharon, Israel
Sponsors and Collaborators
Shalvata Mental Health Center
Investigators
Principal Investigator: Eiran V Harel, MD Shalvata MHC
  More Information

No publications provided

Responsible Party: Hilik Levkovitz, shalvataMHC
ClinicalTrials.gov Identifier: NCT00445926     History of Changes
Other Study ID Numbers: SH-40206
Study First Received: March 8, 2007
Last Updated: May 5, 2010
Health Authority: Israel: Ministry of Health

Additional relevant MeSH terms:
Schizophrenia
Schizophrenia and Disorders with Psychotic Features
Mental Disorders

ClinicalTrials.gov processed this record on May 23, 2013